Trial intelligence / Profile preview

MODERATE: Vitamin D and Uric Acid Lowering in Obesity

NCT01320722Phase 3Completed

Sponsor
Brigham and Women's Hospital
Start
Mar 2011
Primary completion
May 2015
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 3 trial of vitamin d, probenecid, allopurinol in hypertension (HTN), sponsored by Brigham and Women's Hospital. Started Mar 2011; status: completed.

02

Drugs

vitamin dprobenecidallopurinol
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT01320722.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01320722.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call